Cardiovascular disease in diabetes

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Metabolic Disorders

Background:

• Diabetes mellitus is a major risk factor for atherosclerotic vascular disorders, including coronary, cerebrovascular, and peripheral artery disease.
• Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in individuals with diabetes.
• Accelerated atherosclerosis in diabetes necessitates understanding its underlying molecular pathways.

Purpose of the Study:

• To review the molecular mechanisms driving accelerated atherosclerosis in diabetic patients.
• To focus on the roles of postprandial hyperglycemia, advanced glycation end products (AGEs), and the renin-angiotensin system.
• To discuss potential therapeutic strategies targeting CVD in the context of diabetes.

Main Methods:

• Literature review of molecular mechanisms and therapeutic strategies.
• Analysis of the impact of hyperglycemia on vascular health.
• Examination of the role of AGEs and the renin-angiotensin system in diabetic atherosclerosis.

Main Results:

• Diabetes accelerates atherosclerosis through pathways involving postprandial hyperglycemia, AGEs, and the renin-angiotensin system.
• These factors contribute to endothelial dysfunction, inflammation, and plaque formation.
• Specific molecular targets offer potential for novel CVD treatments in diabetes.

Conclusions:

• Understanding the molecular basis of accelerated atherosclerosis in diabetes is crucial for effective CVD prevention and treatment.
• Targeting hyperglycemia, AGEs, and the renin-angiotensin system represents promising therapeutic avenues.
• Further research into these mechanisms can lead to improved cardiovascular outcomes for diabetic populations.